Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01657461 · ClinicalTrials.gov registry record · NA
Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
A NA study of Acute Ischemic Stroke, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
- 1
- Study location
NCT01657461 is a NA study of Acute Ischemic Stroke that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 196 participants, below the 344-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01657461, a NA study of Acute Ischemic Stroke, has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary study objective is to determine if subjects experiencing an acute ischemic stroke due to large vessel occlusion, treated with combined IV t-PA and Solitaire Revascularization Device within 6 hours of symptom onset have less stroke-related neurological disability (mRS) than those subjects treated with IV t-PA alone
Conditions Studied
Interventions
- DRUG Intravenous (IV) recombinant human tissue plasminogen activator (rtPA)
- DEVICE Solitaire revascularization device
Study Locations (1)
New York
- Kaleida Health/Buffalo General - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01657461
The ClinicalTrials.gov registry entry for NCT01657461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 344-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (43% lower). The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Intravenous (IV) recombinant human tissue plasminogen activator (rtPA) is the first listed.
NCT01657461 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01657461 about?
NCT01657461 is a clinical study titled "Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial". The primary study objective is to determine if subjects experiencing an acute ischemic stroke due to large vessel occlusion, treated with combined IV t-PA and Solitaire Revascularization Device within 6 hours of symptom onset have less stroke-related neurological disability (mRS) than those subjects...
What is the current status of trial NCT01657461?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2012-12. Estimated completion is 2015-01.
What conditions does trial NCT01657461 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke.
What interventions are being tested in trial NCT01657461?
The interventions under investigation include: Intravenous (IV) recombinant human tissue plasminogen activator (rtPA) (DRUG), Solitaire revascularization device (DEVICE).
Who is sponsoring clinical trial NCT01657461?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01657461 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
RECRUITING · NA
-
The Pivotal Study of RapidPulseTM Aspiration System
RECRUITING · NA
-
An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke
ACTIVE NOT RECRUITING · NA
-
Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI
ACTIVE NOT RECRUITING · NA
-
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.